Replay available

Exagen Inc. (XGN) Q2 2026 Earnings Call

Exagen Inc. (NASDAQ: XGN) Q2 2026 earnings conference call, held 2026-08-04. Replay captured from the company's public earnings webcast.

Tue, August 4, 2026 at 8:30 AMendedReplay
Exagen Inc. (XGN) Q2 2026 Earnings Call

Investor webinar replay

Latest press releases

Companies on this event

Featured Presenters

Tina Jacobsen

Investor Relations

John Aballi

President & Chief Executive Officer

Jeff Black

Chief Financial Officer

Bill Bonello

Analyst, Craig Hallam Capital Group

Kyle Mixon

Analyst, Canaccord Genuity

Max Masucci

Analyst, Ross Capital Partners

Mark Massaro

Analyst, BTIG

Matt Parisi

Analyst, KeyBank Capital Markets

Replay transcript excerpt

Greetings and welcome to the Exogen Inc. Q2 2026 earnings call. At this time, all participants are in a listen-only mode. A brief question and answer session will follow the formal presentation. Should anyone require operator assistance during the conference, please press star zero on your telephone keypad. As a reminder, this conference is being recorded. It is now my pleasure to introduce your hosts, Tina Jacobsen and Bester Relations. Thank you. You may begin. Thanks, operator. Good morning, and thank you for joining us to discuss Exogen's financial results for the quarter ended June 30, 2026. Today, I'm joined by John Aballi, our President and Chief Executive Officer, and Jeff Black, our Chief Financial Officer. The recording of this call, the press release announcing our financial results, and a slide presentation can be accessed on our website at www.exogen.com. Today's call will include forward-looking statements. We encourage you to review the statements contained in today's press release and the risk and uncertainties described in our SEC filings, which identify certain factors that may cause the company's actual events, performance, and results to differ materially from those contained in the forward-looking statements made on today's call. We also will discuss non-GAAP financial measures on this call. Descriptions of these non-GAAP financial measures and the reconciliations of GAAP to non-GAAP financial measures are included in today's press release. And now, I will turn the call over to John Aballi. John? Good morning, everyone, and thank you for joining us today. The second quarter was an outstanding one at Exogen, and there's a lot to be excited about, so I'll get right into the details. This morning, we reported revenue of $19.9 million, up 16% year ov...

More from Exagen Inc.